Servizio Comunitario di Informazione in materia di Ricerca e Sviluppo - CORDIS

H2020

EbolaVac

Project ID: 666085
Finanziato nell'ambito di

Development of a Chimpanzee Adenovirus Type 3 Ebolavirus Zaire Vaccine

Dal 2014-10-07 al 2017-10-06, progetto in corso

Dettagli del progetto

Costo totale:

EUR 22 055 090,88

Contributo UE:

EUR 15 153 216

Coordinato in:

Belgium

Argomento (i):

Health - Health

Invito a presentare proposte:

H2020-Adhoc-2014-20See other projects for this call

Meccanismo di finanziamento:

RIA - Research and Innovation action

Obiettivo

Informazioni correlate

Coordinatore

GlaxoSmithKline Biologicals
Belgium

Contributo UE: EUR 14 103 135


Rue de l'Institut 89
1330 Rixensart
Belgium
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)

Partecipanti

THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD
United Kingdom

Contributo UE: EUR 942 581


University Offices, Wellington Square
OX1 2JD OXFORD
United Kingdom
Activity type: Higher or Secondary Education Establishments
BERNHARD-NOCHT-INSTITUT FUER TROPENMEDIZIN
Germany

Contributo UE: EUR 107 500


BERNHARD NOCHT STRASSE 74
20359 HAMBURG
Germany
Activity type: Research Organisations
CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS
Switzerland

Contributo UE: EUR 0


RUE DU BUGNON 21
1005 LAUSANNE
Switzerland
Activity type: Public bodies (excluding Research Organisations and Secondary or Higher Education Establishments)
Numero di registrazione: 196375 / Ultimo aggiornamento: 2016-07-04